Active, not recruitingPhase 3NCT04683003

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Studying Thrombotic thrombocytopenic purpura

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Takeda
Principal Investigator
Study Director
Takeda
Intervention
TAK-755(biological)
Enrollment
77 enrolled
Eligibility
70 years · All sexes
Timeline
20212027

Study locations (27)

Collaborators

Takeda Development Center Americas, Inc. · Shire

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04683003 on ClinicalTrials.gov

Other trials for Thrombotic thrombocytopenic purpura

Additional recruiting or active studies for the same condition.

See all trials for Thrombotic thrombocytopenic purpura

← Back to all trials